David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Science and Engineering Ethics 1 (3):283-298 (1995)
The historical background of the discovery of adverse health effects of medicines, food additives, pesticides, and other chemicals is reviewed, and the development of national and international regulations and testing procedures to protect the public against the toxic effects of these drugs and chemicals is outlined. Ethical considerations of the safety evaluation of drugs and chemicals by human experimentation and animal toxicity studies, ethical problems associated with clinical trials, with the falsification of clinical and toxicological data, and with inadequate experimental methodology, are reviewed, and the ethics of the marketing of drugs and their post-marketing surveillance, are similarly considered. These ethical problems are illustrated with many specific examples, including the drugs neoarsphenamine, chloramphenicol, thalidomide, diethyl stilboestrol and benoxaprofen.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Paolo Palladino, Gregg Mitman & Sarah Jansen (2003). Chemicals in the Field - Edmund Russell, War and Nature: Fighting Humans and Insects with Chemicals From World War I to Silent Spring. [REVIEW] Metascience 12 (1):3-23.
Peter Graeme Hobbins (2005). Compromised Ethical Principles in Randomised Clinical Trials of Distant, Intercessory Prayer. Journal of Bioethical Inquiry 2 (3):142-152.
Daniel Sperling (2010). Food Law, Ethics, and Food Safety Regulation: Roles, Justifications, and Expected Limits. [REVIEW] Journal of Agricultural and Environmental Ethics 23 (3):267-278.
Thomas C. Jones (2005). A Call to Restructure the Drug Development Process: Government Over-Regulation and Non-Innovative Late Stage (Phase III) Clinical Trials Are Major Obstacles to Advances in Health Care. Science and Engineering Ethics 11 (4):575-587.
Dennis John Mazur (2007). Evaluating the Science and Ethics of Research on Humans: A Guide for Irb Members. Johns Hopkins University Press.
Udo Schüklenk & Christopher Lowry (2009). Terminal Illness and Access to Phase 1 Experimental Agents, Surgeries and Devices: Reviewing the Ethical Arguments. British Medical Bulletin 89 (1):7-22.
Michael Huemer (2008). The Drug Laws Don't Work. The Philosophers' Magazine (41):71-75.
George G. Brenkert (2008). Marketing Ethics. Blackwell Pub..
Beniamino T. Cenci Goga & Francesca Clementi (2002). Safety Assurance of Foods: Risk Management Depends on Good Science but It is Not a Scientific Activity. [REVIEW] Journal of Agricultural and Environmental Ethics 15 (3):303-313.
Jacek Spławiński, Jerzy Kuźniar, Krzysztof Filipiak & Waldemar Zieliński (2006). Evaluation of Drug Toxicity in Clinical Trials. Science and Engineering Ethics 12 (1):139-145.
Added to index2009-01-28
Total downloads7 ( #304,000 of 1,726,249 )
Recent downloads (6 months)4 ( #183,615 of 1,726,249 )
How can I increase my downloads?